Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurology, Neurosurgery, and Psychiatry|October 6, 2023
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damageDaniel Jons, Viktor Grut, Tomas Bergström, et al.
Neurology|June 10, 2025
Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the Swedish Nationwide GEMG StudyMalin Petersson, Daniel Jons, Amalia Feresiadou, et al.
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Frontiers in Immunology|February 11, 2020
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple SclerosisElin Engdahl, Rasmus Gustafsson, Jesse Huang, et al.
Pageof 2